Adlai Nortye Initiated With Buy on Differentiated RAS-Targeting Pipeline, ADC Strategy and Solid Cash RunwayTip Ranks·Jul 27 at 09:55 AMANL-3.69%
Adlai Nortye Ltd. Sponsored ADR (ANL) Receives a Buy from Cantor FitzgeraldTip Ranks·Jul 20 at 04:06 AMANL-3.69%
Adlai Nortye: Buy Rating Reaffirmed as Dual-Arm AN9025 Strategy Advances; $20 Price Target MaintainedTip Ranks·Jul 16 at 11:45 AMANL-3.69%
Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025Unusual Whales·Jul 16 at 06:03 AMANL-3.69%
Top Biotech Gainers: APLM Climbs 22%; IOVA, RCEL On Watch; MANE Gains On Hair Loss Datarttnews·Jul 15 at 10:42 PMIOVA-5.33%MANE-0.86%
Adlai Nortye director Roger Sawhney files initial beneficial ownership statementPUBT·Jul 15 at 09:33 AMANL-3.69%
Adlai Nortye adds MD Anderson’s David Hong, MSK’s Piro Lito to scientific advisory boardPUBT·Jul 13 at 06:05 AMANL-3.69%
Top Biotech Gainers: LUCY Shines, SEER Gets Takeover Offer, OFIX, ENOV Rally On CMS Updaterttnews·Jul 6 at 10:12 PMSEER+6.55%LUCYW0.00%
U.S. stock market midday update: Adlai Nortye up 9.38%, active funds, sector trends driving volatilityPrice Alert·Jul 6 at 01:17 PMANL-3.69%
Adlai Nortye shares are trading higher after Cantor Fitzgerald initiated its coverage on the stock with an Overweight rating.benzinga_article·Jun 22 at 10:26 AMANL-3.69%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Apr 16 at 07:07 AMANL-3.69%CDNA+10.14%
Adlai Nortye shares are trading higher after the company announced it has entered into a $150 million securities purchase agreement for a private investment in public equity financing.benzinga_article·Apr 16 at 06:42 AMANL-3.69%SBIO0.00%
U.S. stock night market fluctuations: Adlai Nortye rose 3.55% in the night market, analysts' hold ratings fail to boost market confidence, funds flow to other stocksPrice Alert·Apr 16 at 12:37 AMANL-3.69%
